A new HLA-B allele, HLA-B*35:481.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
08 2021
Historique:
revised: 28 09 2020
received: 28 08 2020
accepted: 29 09 2020
pubmed: 3 10 2020
medline: 12 8 2021
entrez: 2 10 2020
Statut: ppublish

Résumé

The novel allele HLA-B*35:481 differs from HLA-B*35:05:01 by two nucleotide substitution in exon 3.

Identifiants

pubmed: 33006203
doi: 10.1111/tan.14087
doi:

Substances chimiques

HLA-B Antigens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-160

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Valeria Miotti (V)

Laboratorio d'Immunogenetica, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Mariarosa Battarra (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Chiara Sindici (C)

Laboratorio d'Immunogenetica, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Donatella Londero (D)

Laboratorio d'Immunogenetica, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Marco Andreani (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH